COMPASS Pathways plc (CMPS)
Healthcare • Medical Care Facilities
StockNasdaqGSUnited KingdomUS20451W1018
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by COMPASS Pathways plc, and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 12 Nov 2026 20:22. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 23 Mar 2027 09:00 | -0.39 | — | — | Upcoming |
| 03 Nov 2026 08:00 | -0.33 | -0.34 | -1.6% | Miss |
| 05 Aug 2026 06:00 | -0.33 | -0.36 | -6.6% | Miss |
| 13 May 2026 06:00 | -0.31 | -0.30 | +3.2% | Beat |
| 24 Mar 2026 07:00 | -0.39 | -0.61 | -55.5% | Miss |
| 04 Nov 2025 06:00 | -0.40 | -0.38 | +5.3% | Beat |
| 31 Jul 2025 06:00 | -0.37 | -0.41 | -11.2% | Miss |
| 08 May 2025 06:00 | -0.49 | -0.42 | +14.6% | Beat |
| 27 Feb 2025 06:00 | -0.64 | -0.63 | +1.8% | Beat |
| 31 Oct 2024 06:00 | -0.59 | -0.56 | +4.4% | Beat |
| 01 Aug 2024 06:00 | -0.55 | -0.56 | -2.6% | Miss |
| 08 May 2024 06:00 | -0.44 | -0.55 | -26.0% | Miss |
| 29 Feb 2024 07:00 | -0.34 | -0.53 | -57.0% | Miss |
| 02 Nov 2023 07:00 | -0.42 | -0.67 | -57.7% | Miss |
| 03 Aug 2023 06:00 | -0.70 | -0.62 | +11.6% | Beat |
| 11 May 2023 07:00 | -0.65 | -0.57 | +11.8% | Beat |
| 28 Feb 2023 07:00 | -0.63 | -0.73 | -15.1% | Miss |
| 03 Nov 2022 07:00 | -0.64 | -0.43 | +32.8% | Beat |
| 04 Aug 2022 07:00 | -0.60 | -0.50 | +17.2% | Beat |
| 10 May 2022 06:00 | -0.65 | -0.50 | +23.5% | Beat |
| 24 Feb 2022 07:00 | -0.50 | -0.61 | -22.9% | Miss |
| 09 Nov 2021 07:00 | -0.47 | -0.38 | +19.9% | Beat |
| 11 Aug 2021 06:00 | -0.37 | -0.44 | -18.9% | Miss |
| 13 May 2021 06:00 | -0.52 | -0.35 | +33.1% | Beat |
| 09 Mar 2021 07:00 | -1.39 | -0.52 | +62.7% | Beat |
| 12 Nov 2020 07:00 | -0.68 | -0.46 | +32.4% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 0 | — | -287.9M | — | -3.08 | -33.9% | -157.2M |
| 2024 | 0 | — | -155.1M | — | -2.30 | +0.9% | -119.2M |
| 2023 | 0 | — | -118.5M | — | -2.32 | -7.4% | -97.4M |
| 2022 | 0 | — | -91.5M | — | -2.16 | — | -106M |
| 2021 | — | — | — | — | — | — | — |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 12 Nov 2026 | 9.02 | 9.34 | 8.85 | 9.11 | -2.04% | 1,348,167 | |
| 11 Nov 2026 | 9.50 | 9.50 | 9.03 | 9.30 | +0.54% | 2,623,400 | |
| 10 Nov 2026 | 9.01 | 9.49 | 8.90 | 9.25 | +0.76% | 2,637,900 | |
| 09 Nov 2026 | 8.87 | 9.28 | 8.56 | 9.18 | +6.62% | 3,405,100 | |
| 06 Nov 2026 | 8.05 | 8.68 | 7.99 | 8.61 | +10.24% | 3,757,100 | |
| 05 Nov 2026 | 8.46 | 8.61 | 7.78 | 7.81 | -9.19% | 5,535,800 | |
| 04 Nov 2026 | 8.53 | 8.88 | 8.05 | 8.60 | +0.12% | 5,253,500 | |
| 03 Nov 2026 | 9.00 | 9.49 | 8.47 | 8.59 | +2.14% | 8,845,400 | |
| 02 Nov 2026 | 11.71 | 11.76 | 7.54 | 8.41 | -27.31% | 16,850,600 | |
| 30 Oct 2026 | 11.82 | 11.99 | 11.27 | 11.57 | -5.09% | 2,180,300 | |
| 1,245 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- COMPASS Pathways (CMPS) Could Be 62% Undervalued As FDA Filing Sharpens The Case (opens in a new tab) Simply Wall St. · 12 Nov 2026 20:13
- Compass Pathways Completes FDA Application for Psilocybin Therapy, Prepares for Launch (opens in a new tab) MarketBeat · 12 Nov 2026 11:13
- Compass Pathways to Participate in Jefferies Global Healthcare Conference on November 18th and 19th (opens in a new tab) 11 Nov 2026 11:30
- Compass Pathways PLC (CMPS) (Q3 2026) Earnings Call Highlights: $444 Million Cash Runway, FDA ... (opens in a new tab) GuruFocus.com · 11 Nov 2026 05:06
- Compass Pathways could secure US approval for depression drug by early 2027, Jefferies says (opens in a new tab) Proactive · 09 Nov 2026 19:00
- Compass Pathways stock gains on FDA filing for depression drug (opens in a new tab) Investing.com · 09 Nov 2026 18:09
- Compass Pathways Completes COMP360 Psilocybin New Drug Application to U.S. FDA for Treatment-Resistant Depression (opens in a new tab) 09 Nov 2026 11:30
- Compass Pathways Submits FDA New Drug Application For Comp360 Psilocybin For Treatment-Resistant Depression (opens in a new tab) Benzinga · 09 Nov 2026 07:33
- HC Wainwright & Co. Reiterates Buy on Compass Pathways, Maintains $65 Price Target (opens in a new tab) Benzinga · 09 Nov 2026 07:09
- Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (opens in a new tab) 05 Nov 2026 21:30
- Is COMPASS Pathways (CMPS) Pricing In Too Much On Book Value? (opens in a new tab) Simply Wall St. · 05 Nov 2026 19:09
- How Investors May Respond To COMPASS Pathways (CMPS) Smaller Loss And FDA Progress (opens in a new tab) Simply Wall St. · 04 Nov 2026 06:16
- Compass Pathways: 3 Key Takeaways for Long-Term Investors (opens in a new tab) Motley Fool · 04 Nov 2026 04:51
- Compass Pathways (CMPS) Q3 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 03 Nov 2026 20:39
- Compass Pathways Q3 Earnings Call Highlights (opens in a new tab) MarketBeat · 03 Nov 2026 16:14
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 9.30 USD
- Market cap
- 1.3B
- Exchange
- NasdaqGS
- Country
- United Kingdom
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Currency
- USD
Dividends
No dividends on record.
Why this score
| Part of the score | Points | Why |
|---|---|---|
| Business growth Yearly growth of revenue and of earnings per share. | 8.8 / 25 No figures for this part: it counts as a cautious 35%. | — |
| Quality Return on equity, net margin and how stable the margins are. | 0.0 / 25 |
|
| Financial strength Net debt against operating earnings, interest cover and free cash flow. | 9.7 / 20 |
|
| Valuation Free cash flow yield and the P/E against its sector. | 7.0 / 15 | — |
| Analysts How far the analysts' average target is from today's price. | 10.0 / 10 |
|
- Score capped at 60: free cash flow was negative in two of the last three years
- Thin interest cover: operating profit is only -38.8× the interest
- The last full year was a loss
Growth profile: it pays no dividend, so it is scored on business growth, quality and financial strength. Based on 70% of the figures (grade C). Warnings take 12 points off.
Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio. How the score works
Figures
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| P/E (forward) | -6.32× | Weak | 14.16× |
| Price / book | 9.09× | Weak | 3.5× |
| EV / EBITDA | -4.57× | Weak | 11.19× |
| Free cash flow yield | 2.8% | Fair | 2.1% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Gross margin | 0% | Weak | 54.9% |
| Operating margin | 0% | Weak | 5.8% |
| Net margin | 0% | Weak | 1.2% |
| Return on equity | -296.5% | Weak | 4.4% |
| Return on assets | -32.8% | Weak | 2.7% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Debt / equity | 0.38× | Good | 0.4× |
| Interest cover | -38.81× | Weak | 2.17× |
| Current ratio | 1.5× | Fair | 2.64× |
The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.
Similar shares
Follow CMPS and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.